FDA Adverse Event Injury Summary report: N

CERTAS INLIN VLV ONLY W/SPHNGD

MDR report key: 3449946 · Received November 5, 2013

Report

Report Number
1226348-2013-32529
Event Type
Injury
Date Received
November 5, 2013
Report Date
February 24, 2012
Manufacturer
CODMAN & SHURTLEFF, INC MEDOS
Product Code
JXG
PMA / PMN Number
PK112156
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

IT HAS BEEN COMMUNICATED THAT THE DEVICE AND/OR LOT INFORMATION IS NOT AVAILABLE FOR EVALUATION. WITHOUT THE DEVICE AND/OR LOT INFORMATION IT IS NOT POSSIBLE FOR CODMAN TO CONDUCT A PROPER INVESTIGATION. IF AT SOME POINT THE DEVICE AND/OR LOT INFORMATION DOES BECOME AVAILABLE, THIS COMPLAINT WILL BE RE-OPENED, EVALUATED AND A FOLLOW UP REPORT WILL BE FILED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CONSIDERED CLOSED. DEVICE REMAINS IMPLANTED.

Additional Manufacturer Narrative · 1

IT HAS BEEN COMMUNICATED THAT THE DEVICE AND/OR LOT INFORMATION IS NOT AVAILABLE FOR EVALUATION. WITHOUT THE DEVICE AND/OR LOT INFORMATION IT IS NOT POSSIBLE FOR CODMAN TO CONDUCT A PROPER INVESTIGATION. IF AT SOME POINT THE DEVICE AND/OR LOT INFORMATION DOES BECOME AVAILABLE, THIS COMPLAINT WILL BE RE-OPENED, EVALUATED AND A FOLLOW UP REPORT WILL BE FILED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CONSIDERED CLOSED.

Description of Event or Problem · 1

COMPLAINT PERTAINS TO (B)(4). IT HAS BEEN DECIDED THAT THE COMPLAINT IS REPORTABLE. AS A RESULT A MEDWATCH REPORT IS BEING FILED. REP REPORTED THAT SHE RECEIVED A CALL FROM SURGEON ON (B)(6) 2011 AND HE STATED THAT HE WAS HAVING TROUBLE VERIFYING THE CERTAS VALVE SETTING (B)(4) WITH THE VERIFICATION TOOL. THE PROCEDURE HAD TAKEN PLACE ON (B)(6) 2012 AND THE PATIENTS SCALP WAS SWOLLEN FROM THE PROCEDURE, AND THE PATIENT ALSO HAD SEVERAL PREVIOUS PROCEDURES THAT CAUSED SCAR TISSUE BELOW THE INCISION SITE. REP WENT IN TO MEET WITH SURGEON SO SHE COULD HELP GUIDE HIM THROUGH THE VERIFICATION PROCESS. THE VERIFICATION TOOL WAS SPINNING AND READING VARIOUS INACCURATE SETTINGS. SURGEON HAD CALLED FOR X-RAYS PRIOR TO MY ARRIVAL, BUT BECAUSE THE VALVE DOES NOT HAVE ANY ORIENTATION MARKERS, WE WERE NOT ABLE TO VERIFY WHERE THE VALVE WAS SET BASED ON THE X-RAYS THAT HAD BEEN TAKEN. ONCE WE WERE ABLE TO VERIFY THAT THE X-RAY HAD BEEN TAKEN PROPERLY, WE WERE ABLE TO VERIFY THE VALVE SETTING. THE PATIENT WAS DOING WELL THROUGHOUT THE PROCESS, AS SURGEON STATES IN HIS EMAIL BELOW. THESE EVENTS HAPPENED OVER THE COURSE OF FOUR DAYS, (B)(6) 2011.

Description of Event or Problem · 1

A FOLLOW UP REPORT IS BEING FILED AS THE INITIAL REPORTING DECISION HAS CHANGED. THE COMPLAINT IS NOW BEING FILED AS A SERIOUS INJURY. REP REPORTED THAT SHE RECEIVED A CALL FROM SURGEON ON 12/18/2011 AND HE STATED THAT HE WAS HAVING TROUBLE VERIFYING THE CERTAS VALVE SETTING (82-8804) WITH THE VERIFICATION TOOL. THE PROCEDURE HAD TAKEN PLACE ON (B)(6) 2012 AND THE PATIENTS SCALP WAS SWOLLEN FROM THE PROCEDURE, AND THE PATIENT ALSO HAD SEVERAL PREVIOUS PROCEDURES THAT CAUSED SCAR TISSUE BELOW THE INCISION SITE. REP WENT IN TO MEET WITH SURGEON SO SHE COULD HELP GUIDE HIM THROUGH THE VERIFICATION PROCESS. THE VERIFICATION TOOL WAS SPINNING AND READING VARIOUS INACCURATE SETTINGS. SURGEON HAD CALLED FOR X-RAYS PRIOR TO MY ARRIVAL, BUT BECAUSE THE VALVE DOES NOT HAVE ANY ORIENTATION MARKERS, WE WERE NOT ABLE TO VERIFY WHERE THE VALVE WAS SET BASED ON THE X-RAYS THAT HAD BEEN TAKEN. ONCE WE WERE ABLE TO VERIFY THAT THE X-RAY HAD BEEN TAKEN PROPERLY, WE WERE ABLE TO VERIFY THE VALVE SETTING. THE PATIENT WAS DOING WELL THROUGHOUT THE PROCESS, AS SURGEON STATES IN HIS EMAIL BELOW. THESE EVENTS HAPPENED OVER THE COURSE OF FOUR DAYS, (B)(6) 2011-(B)(6) 2011.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
568808 CERTAS INLIN VLV ONLY W/SPHNGD SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF, INC MEDOS

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention